Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9089471 | GENUS | Formulation of indomethacin |
Apr, 2030
(5 years from now) | |
US8734847 | GENUS | Formulation of indomethacin |
Apr, 2030
(5 years from now) | |
US8992982 | GENUS | Formulation of indomethacin |
Apr, 2030
(5 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Product(NP) | Feb 24, 2017 |
Drugs and Companies using INDOMETHACIN ingredient
Market Authorisation Date: 24 February, 2014
Treatment: Treatment of pain
Dosage: CAPSULE;ORAL